A.I cancer screening start-up gets government backing

Five-years worth of grants will be used to fund a laboratory centre in Graz, research equipment and academic expertise to develop cancer screening technology. Following trails with the NHS, which saw medtech start-up Lancor Scientifics improve upon the current 60% to 70% accuracy for cervical cancer screening by pathologists, the new centre plans to achieve 90% accuracy with its patented Tumour Trace OMIS (Opto-magnetic Imaging Spectroscopy) device by using artificial intelligence (A.I). The device, which detects the change of electromagnetism within tissue on quantum levels, will aim...